+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy

Statin-Induced Cholesterol Lowering and Plaque Regression After 6 Months of Magnetic Resonance Imaging-Monitored Therapy

Acc Current Journal Review 14(5): 23-24

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 063408001

Download citation: RISBibTeXText

DOI: 10.1016/j.accreview.2005.04.060

Related references

Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110(16): 2336-2341, 2004

Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy. Journal of Cardiovascular Medicine 9(7): 700-706, 2008

Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study. Atherosclerosis 232(1): 31-39, 2014

Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thickness. Journal of Cardiovascular Magnetic Resonance 13: 37-37, 2011

Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging. Atherosclerosis 245(): 74-81, 2016

Are Patients with Low Non-HDL Cholesterol "Non-responders" to Statin Therapy on Coronary Plaque Regression?. Journal of Atherosclerosis and Thrombosis 23(9): 1030-1032, 2016

Pravastatin-induced reduction in leukocyte count is associated with coronary plaque regression Possible role of non-lipid lowering effects of statin. Circulation 108(17 Supplement): IV-21, October 28, 2003

Marked regression of aortic plaque by intensive cholesterol-lowering therapy. Journal of Atherosclerosis and Thrombosis 18(5): 421-424, 2011

Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes. Circulation 94(8 SUPPL ): I579, 1996

Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels. Journal of Atherosclerosis and Thrombosis 23(9): 1055-1066, 2016

Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study. Stroke 47(7): 1789-1796, 2017

Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study. Journal of Cardiovascular Pharmacology 25 Suppl 4: S25-S31, 1995

Effect of intensive statin therapy on regression of carotid intima-media thickness in patients with subclinical carotid atherosclerosis (a prospective, randomized trial: PEACE (Pitavastatin Evaluation of Atherosclerosis Regression by Intensive Cholesterol-lowering Therapy) study). European Journal of Preventive Cardiology 20(6): 1069-1079, 2014

Coronary plaque regression over twelve months is correlated with increase in high-density lipoprotein cholesterol levels during therapy. Journal of the American College of Cardiology 35(2 suppl A): 257A, 2000

Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy. Journal of Stroke and Cerebrovascular Diseases 23(9): 2425-2430, 2015